Natural History and Surgical Outcomes of Lamellar Macular Holes.

Lamellar macular hole Natural history OCT Surgery Vitrectomy

Journal

Ophthalmology. Retina
ISSN: 2468-6530
Titre abrégé: Ophthalmol Retina
Pays: United States
ID NLM: 101695048

Informations de publication

Date de publication:
22 Sep 2023
Historique:
received: 15 04 2023
revised: 09 09 2023
accepted: 18 09 2023
pubmed: 25 9 2023
medline: 25 9 2023
entrez: 24 9 2023
Statut: aheadofprint

Résumé

To assess the natural history and surgical outcomes of lamellar macular holes (LMHs). Retrospective and consecutive case series. Patients with LMHs from multiple tertiary care centers. Clinical charts and OCT scans were reviewed. The visual acuity (VA) changes and the occurrence rate of full-thickness macular hole (FTMH) were studied in both groups. Within the operated group, factors associated with 6-month VA and development of FTMH were explored. One hundred seventy-eight eyes were included, of which 89 were monitored and 89 underwent surgery. In the observation group, the mean VA decreased from 0.25 ± 0.18 to 0.28 ± 0.18 logarithm of the minimum angle of resolution (logMAR; P = 0.13), with 14 eyes (15.7%) that lost ≥ 0.2 logMAR VA, after 45.7 ± 33.3 months. Nine eyes (10.1%) spontaneously developed an FTMH. In the operated group, the mean VA increased from 0.47 ± 0.23 to 0.35 ± 0.25 logMAR at 6 months (P < 0.001) and 0.36 ± 0.28 logMAR (P = 0.001) after 24.1 ± 30.1 months. By multivariate analysis, better baseline VA (P < 0.001), the presence of an epiretinal membrane (P = 0.03), and the peeling of the internal limiting membrane (ILM; P = 0.02), with a greater effect of ILM perihole sparing, were associated with a greater 6-month VA. Perihole epiretinal proliferation sparing was associated with a better postoperative VA by univariate analysis (P = 0.03), but this was not significant by multivariate analysis. Eight eyes (9.0%) developed a postoperative FTMH. Using Cox proportional hazard ratios [HRs], pseudophakia at baseline (HR, 0.06; 95% confidence interval [CI], 0.00-0.75; P = 0.03) and peeling of the ILM (HR, 0.05; 95% CI, 0.01-0.39; P = 0.004) were protective factors, while ellipsoid zone disruption (HR, 10.5; 95% CI, 1.04-105; P = 0.05) was associated with an increased risk of FTMH. Observed eyes with LMH experienced, on average, progressive VA loss. Patients with LMH and altered vision may benefit from surgery. Internal limiting membrane peeling, with perihole ILM sparing, represents a crucial step of the surgery associated with a greater VA and a lower risk of postoperative FTMH. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Identifiants

pubmed: 37743020
pii: S2468-6530(23)00482-7
doi: 10.1016/j.oret.2023.09.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Ismael Chehaibou (I)

Ophthalmology Department, Hôpital Fondation Adolphe de Rothschild, Paris, France.

Ramin Tadayoni (R)

Ophthalmology Department, Hôpital Fondation Adolphe de Rothschild, Paris, France; Université Paris Cité, AP-HP, Hôpital Lariboisière, Paris, France.

Jean-Pierre Hubschman (JP)

Retina Division, Stein Eye Institute, University of California Los Angeles, Los Angeles, California.

Ferdinando Bottoni (F)

Eye Clinic, Department of Biomedical and Clinical Science "Luigi Sacco," Sacco Hospital, University of Milan, Milan, Italy.

Georges Caputo (G)

Ophthalmology Department, Hôpital Fondation Adolphe de Rothschild, Paris, France.

Stanley Chang (S)

Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, New York.

Roberto Dell'Omo (R)

Department of Medicine and Health Sciences "Vincenzo Tiberio," University of Molise, Campobasso, Italy.

Marta S Figueroa (MS)

Clinica Baviera, Department of Ophthalmology, Ramon y Cajal University Hospital, University of Alcala de Henares, Madrid, Spain.

Alain Gaudric (A)

Université Paris Cité, AP-HP, Hôpital Lariboisière, Paris, France.

Christos Haritoglou (C)

Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany.

Kazuaki Kadonosono (K)

Department of Ophthalmology and micro-technology, Yokohama City University Medical School, Yokohama, Japan.

Christoph Leisser (C)

VIROS-Vienna Institute for Research in Ocular Surgery, a Karl Landsteiner Institute, Vienna, Austria.

Mathias Maier (M)

Klinik und Poliklinik für Augenheilkunde, Technische Universität München, Munich, Germany.

Siegfried Priglinger (S)

Augenklinik der LMU, Klinikum der Universität München, Munich, Germany.

Stanislao Rizzo (S)

Department of Ophthalmology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Dipartimento Testa-collo e organi di senso, Università Cattolica del Sacro Cuore, Rome, Italy; Istituto di Neuroscienze, Consiglio Nazionale della Ricerca, Pisa, Italy.

Ricarda G Schumann (RG)

Eye and Vascular Medicine Center, Ludwig-Maximilians-University, Munich, Germany.

Jerry Sebag (J)

VMR Institute for Vitreous Macula Retina, Huntington Beach, California; Doheny Eye Institute, UCLA, Pasadena, California; Department of Ophthalmology, David Geffen School of Medicine, UCLA, Los Angeles, California.

Miroslav Stamenkovic (M)

Eye clinic, University Hospital Zvezdara, Belgrad, Serbia.

Marc Veckeneer (M)

Department of Ophthalmology, ZNA Middelheim Hospital, Antwerp, Belgium.

David H Steel (DH)

Ophthalmology, Sunderland Eye Infirmary, Sunderland, United Kingdom; Bioscience Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom. Electronic address: david.steel@newcastle.ac.uk.

Classifications MeSH